Interim results from a phase I randomized, placebo-controlled trial of novel SARS-CoV-2 beta variant receptor-binding domain recombinant protein and mRNA vaccines as a 4th dose booster
Titel:
Interim results from a phase I randomized, placebo-controlled trial of novel SARS-CoV-2 beta variant receptor-binding domain recombinant protein and mRNA vaccines as a 4th dose booster
Auteur:
Nolan, Terry M. Deliyannis, Georgia Griffith, Maryanne Braat, Sabine Allen, Lilith F. Audsley, Jennifer Chung, Amy W. Ciula, Marcin Gherardin, Nicholas A. Giles, Michelle L. Gordon, Tom P. Grimley, Samantha L. Horng, Lana Jackson, David C. Juno, Jennifer A. Kedzierska, Katherine Kent, Stephen J. Lewin, Sharon R. Littlejohn, Mason McQuilten, Hayley A. Mordant, Francesca L. Nguyen, Thi H.O. Soo, Vanessa Pac Price, Briony Purcell, Damian F.J. Ramanathan, Pradhipa Redmond, Samuel J. Rockman, Steven Ruan, Zheng Sasadeusz, Joseph Simpson, Julie A. Subbarao, Kanta Fabb, Stewart A. Payne, Thomas J. Takanashi, Asuka Tan, Chee Wah Torresi, Joseph Wang, Jing Jing Wang, Lin-Fa Al-Wassiti, Hareth Wong, Chinn Yi Zaloumis, Sophie Pouton, Colin W. Godfrey, Dale I.